Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-11

Clinical Trial Update: Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood [NA]

View source ↗

Summary

Completed clinical trial evaluating whether omega-3 fatty acids can reduce diabetes risk in subjects with a high number of particles carrying 'bad cholesterol' …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: May Faraj, PDt, PhD | Conditions: Type 2 Diabetes, Insulin Sensitivity/Resistance | NA | Status: COMPLETED